Stocks · Health care · Pharmaceutical Preparations

Tyra Biosciences, Inc.

TYRA Clue Score32
United States Fiscal year ends December CIK 0001863127 Results filed 4 Aug 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
Gilla Kaplan
25 Mar 2026
Director
Sold after exercise
14,295
$36.97
$528.51K

What was left out

Form 4 filings counted 29
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 1
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 275,564
History held since 17 Sep 2021